Pieter Johan Adam Eichhorn

12PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersEnvironmentally sustainable engineeringMechanobiologyGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 07, 2026
Global analysis of cancer cell responses to USP9X inhibition.

Philipp Schenk, Shane M Devine, Simon A Cobbold

|Dec 06, 2024
Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Arlene Chan, Jespal Gill, HuiJun Chih

|Dec 15, 2023
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam

|Nov 07, 2023
Deubiquitinases in cancer.

Grant Dewson, Pieter J A Eichhorn, David Komander

|Apr 03, 2021
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity.

Sarah Christine Elisabeth Wright, Natali Vasilevski, Violeta Serra

|Jan 08, 2020
USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.

Sarah Kit Leng Lui, Prasanna Vasudevan Iyengar, Patrick Jaynes

Pageof 2

Frequent Collaborators

4 joint publications

Tuan Zea Tan

4 joint publications

Azad Saei

3 joint publications

Alan Prem Kumar

3 joint publications

Jean Paul Thiery